LYTIR

Company · GILD

Gilead Sciences, Inc.

Name as listed on its exchange; filed with the SEC as GILEAD SCIENCES, INC.

Nasdaq's symbol directory lists GILD on Nasdaq as “Gilead Sciences, Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders sold on 30 occasions ($60.1M); 17 planned-sale notices; 11 congressional trade disclosures; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $60.1M in total.Mar: Insider sales $865KApr: Insider sales $1.3MMay: Insider sales $4.1MJun: Insider sales $2.7MJul: Insider sales $2.7MAug: Insider sales $9.6MSep: Insider sales $3.1MOct: Insider sales $5.9MNov: Insider sales $29.8MDecJanFebMarAprMayJunJulAugSepOctNov$29.8M
Insider purchases above the line: $0Insider sales below: $60.1M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Daniel Patrick O'Day, Chairman & CEO sold on 10 days all under a 10b5-1 plan latest Nov 5, 2026 sold $36.6M
  2. Johanna Mercier, Chief Comm & Corp Aff Officer sold on 8 days all under a 10b5-1 plan latest Nov 16, 2026 sold $14.4M
  3. Andrew D. Dickinson, Chief Financial Officer sold on 8 days all under a 10b5-1 plan latest Nov 16, 2026 sold $3.4M
  4. Anthony Welters sold on 1 day all under a 10b5-1 plan latest Aug 26, 2026 sold $2.7M
  5. Kelly A. Kramer sold on 1 day all under a 10b5-1 plan latest Nov 12, 2026 sold $1.8M
  6. Bluestone Jeffrey sold on 1 day all under a 10b5-1 plan latest Aug 20, 2026 sold $725K
  7. Cain Wettan Keeley M, EVP Gen Counsel, Legal & Comp sold on 1 day all under a 10b5-1 plan latest Nov 6, 2026 sold $558K
Every trade (30)
  1. SELLJohanna Mercier, Chief Comm & Corp Aff Officer sold Nov 16, 2026 28,000 shares 3 legs combined 10b5-1 plan (scheduled) filing $4.8M
  2. SELLAndrew D. Dickinson, Chief Financial Officer sold Nov 16, 2026 3,000 shares 10b5-1 plan (scheduled) filing $514K
  3. SELLKelly A. Kramer sold Nov 12, 2026 10,376 shares 4 legs combined 10b5-1 plan (scheduled) filing $1.8M
  4. SELLCain Wettan Keeley M, EVP Gen Counsel, Legal & Comp sold Nov 6, 2026 3,399 shares 10b5-1 plan (scheduled) filing $558K
  5. SELLDaniel Patrick O'Day, Chairman & CEO sold Nov 5, 2026 9,810 shares 10b5-1 plan (scheduled) filing $1.7M
  6. SELLDaniel Patrick O'Day, Chairman & CEO sold Nov 4, 2026 102,619 shares 10b5-1 plan (scheduled) filing $18.0M
  7. SELLDaniel Patrick O'Day, Chairman & CEO sold Nov 2, 2026 15,000 shares 5 legs combined 10b5-1 plan (scheduled) filing $2.5M
  8. SELLDaniel Patrick O'Day, Chairman & CEO sold Oct 30, 2026 15,881 shares 10b5-1 plan (scheduled) filing $2.8M
  9. SELLAndrew D. Dickinson, Chief Financial Officer sold Oct 15, 2026 3,000 shares 10b5-1 plan (scheduled) filing $469K
  10. SELLJohanna Mercier, Chief Comm & Corp Aff Officer sold Oct 15, 2026 3,000 shares 10b5-1 plan (scheduled) filing $469K
  11. SELLDaniel Patrick O'Day, Chairman & CEO sold Oct 1, 2026 15,000 shares 2 legs combined 10b5-1 plan (scheduled) filing $2.2M
  12. SELLAndrew D. Dickinson, Chief Financial Officer sold Sep 15, 2026 3,000 shares 10b5-1 plan (scheduled) filing $436K
  13. SELLJohanna Mercier, Chief Comm & Corp Aff Officer sold Sep 15, 2026 3,000 shares 3 legs combined 10b5-1 plan (scheduled) filing $433K
  14. SELLDaniel Patrick O'Day, Chairman & CEO sold Sep 1, 2026 15,000 shares 3 legs combined 10b5-1 plan (scheduled) filing $2.2M
  15. SELLAnthony Welters sold Aug 26, 2026 18,000 shares 4 legs combined 10b5-1 plan (scheduled) filing $2.7M
  16. SELLBluestone Jeffrey sold Aug 20, 2026 5,000 shares 5 legs combined 10b5-1 plan (scheduled) filing $725K
  17. SELLJohanna Mercier, Chief Comm & Corp Aff Officer sold Aug 17, 2026 28,000 shares 2 legs combined 10b5-1 plan (scheduled) filing $3.9M
  18. SELLAndrew D. Dickinson, Chief Financial Officer sold Aug 17, 2026 3,000 shares 10b5-1 plan (scheduled) filing $415K
  19. SELLDaniel Patrick O'Day, Chairman & CEO sold Aug 3, 2026 15,000 shares 3 legs combined 10b5-1 plan (scheduled) filing $2.0M
  20. SELLAndrew D. Dickinson, Chief Financial Officer sold Jul 15, 2026 3,000 shares 10b5-1 plan (scheduled) filing $390K
  21. SELLJohanna Mercier, Chief Comm & Corp Aff Officer sold Jul 15, 2026 3,000 shares 10b5-1 plan (scheduled) filing $390K
  22. SELLDaniel Patrick O'Day, Chairman & CEO sold Jul 1, 2026 15,000 shares 2 legs combined 10b5-1 plan (scheduled) filing $1.9M
  23. SELLAndrew D. Dickinson, Chief Financial Officer sold Jun 15, 2026 3,000 shares 10b5-1 plan (scheduled) filing $376K
  24. SELLJohanna Mercier, Chief Comm & Corp Aff Officer sold Jun 15, 2026 3,000 shares 3 legs combined 10b5-1 plan (scheduled) filing $372K
  25. SELLDaniel Patrick O'Day, Chairman & CEO sold Jun 1, 2026 15,000 shares 3 legs combined 10b5-1 plan (scheduled) filing $2.0M
  26. SELLJohanna Mercier, Chief Comm & Corp Aff Officer sold May 15, 2026 28,000 shares 4 legs combined 10b5-1 plan (scheduled) filing $3.7M
  27. SELLAndrew D. Dickinson, Chief Financial Officer sold May 15, 2026 3,000 shares 10b5-1 plan (scheduled) filing $397K
  28. SELLDaniel Patrick O'Day, Chairman & CEO sold Apr 28, 2026 10,000 shares 2 legs combined 10b5-1 plan (scheduled) filing $1.3M
  29. SELLAndrew D. Dickinson, Chief Financial Officer sold Mar 16, 2026 3,000 shares 10b5-1 plan (scheduled) filing $433K
  30. SELLJohanna Mercier, Chief Comm & Corp Aff Officer sold Mar 16, 2026 3,000 shares 10b5-1 plan (scheduled) filing $433K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. JOHANNA MERCIER filed Nov 16, 2026 Officer 28,000 shares planned sale date 11/16/2026 filing $4.8M
  2. ANDREW DICKINSON filed Nov 16, 2026 Officer 3,000 shares planned sale date 11/16/2026 filing $514K
  3. KELLY KRAMER filed Nov 12, 2026 Director 10,376 shares planned sale date 11/12/2026 filing $1.8M
  4. KEELEY M CAIN WETTAN filed Nov 6, 2026 Officer 3,399 shares planned sale date 11/06/2026 filing $570K
  5. DANIEL O'DAY filed Nov 4, 2026 Director 112,429 shares planned sale date 11/04/2026 filing $18.8M
  6. DANIEL O'DAY filed Oct 30, 2026 Director 45,881 shares planned sale date 10/30/2026 filing $7.6M
  7. ANDREW DICKINSON filed Oct 15, 2026 Officer 3,000 shares planned sale date 10/15/2026 filing $469K
  8. JOHANNA MERCIER filed Oct 15, 2026 Officer 3,000 shares planned sale date 10/15/2026 filing $469K
  9. ANDREW DICKINSON filed Sep 15, 2026 Officer 3,000 shares planned sale date 09/15/2026 filing $436K
  10. JOHANNA MERCIER filed Sep 15, 2026 Officer 3,000 shares planned sale date 09/15/2026 filing $433K
  11. ANTHONY WELTERS filed Aug 26, 2026 Director 18,000 shares planned sale date 08/26/2026 filing $2.7M
  12. JEFFREY BLUESTONE filed Aug 20, 2026 Director 5,000 shares planned sale date 08/20/2026 filing $738K
  13. JOHANNA MERCIER filed Aug 17, 2026 Officer 28,000 shares planned sale date 08/17/2026 filing $3.9M
  14. ANDREW DICKINSON filed Aug 17, 2026 Officer 3,000 shares planned sale date 08/17/2026 filing $415K
  15. DANIEL O'DAY filed Aug 3, 2026 Director 55,000 shares planned sale date 08/03/2026 filing $7.2M
  16. ANDREW DICKINSON filed Jul 15, 2026 Officer 3,000 shares planned sale date 07/15/2026 filing $390K
  17. JOHANNA MERCIER filed Jul 15, 2026 Officer 3,000 shares planned sale date 07/15/2026 filing $390K

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Rohit Khanna (D-CA17): Sale Aug 10, 2026 reported Sep 4, 2026 one of 178 trades the member reported that day House owner: dependent $1,001 - $15,000
  2. Rohit Khanna (D-CA17): Purchase Jul 20, 2026 reported Aug 7, 2026 one of 257 trades the member reported that day House owner: spouse $1,001 - $15,000
  3. Rohit Khanna (D-CA17): Sale Jul 7, 2026 reported Aug 7, 2026 one of 257 trades the member reported that day House owner: dependent $1,001 - $15,000
  4. Rohit Khanna (D-CA17): Purchase May 15, 2026 reported Jun 9, 2026 one of 504 trades the member reported that day House owner: spouse $15,001 - $50,000
  5. Jared Moskowitz (D-FL23): Purchase May 6, 2026 reported Jun 19, 2026 one of 4 trades the member reported that day House Stocks (including ADRs) owner: dependent $1,001 - $15,000
  6. Jared Moskowitz (D-FL23): Purchase May 6, 2026 reported Jun 19, 2026 one of 4 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  7. Rohit Khanna (D-CA17): Sale Apr 13, 2026 reported May 11, 2026 one of 348 trades the member reported that day House owner: spouse $15,001 - $50,000
  8. Alan Armstrong (R-OK): Purchase Mar 27, 2026 reported Jul 21, 2026 one of 703 trades the member reported that day Senate Stock $1,001 - $15,000
  9. Rohit Khanna (D-CA17): Purchase Jan 29, 2026 reported Feb 6, 2026 one of 878 trades the member reported that day House owner: spouse $15,001 - $50,000
  10. Josh Gottheimer (D-NJ05): Purchase Jan 27, 2026 reported Feb 26, 2026 one of 6 trades the member reported that day House Stocks (including ADRs) owner: joint $1,001 - $15,000
  11. Rohit Khanna (D-CA17): Sale Jan 23, 2026 reported Feb 6, 2026 one of 878 trades the member reported that day House owner: dependent $1,001 - $15,000

Executive branch · OGE Form 278-T

Reported by the President

13 confirmed trades on scanned reports whose security name matches this company's own filed name exactly (letter case, punctuation and Inc/Corp-style endings aside). All of Donald J. Trump's reports

  1. Sale: GILEAD SCIENCES INC Jul 24, 2026 reported Sep 8, 2026 President Donald J. Trump Periodic Transaction Report 09.08.26 $1,001 – $15,000
  2. Purchase: GILEAD SCIENCES INC Jul 23, 2026 reported Sep 8, 2026 President Donald J. Trump Periodic Transaction Report 09.08.26 $15,001 – $50,000
  3. Purchase: GILEAD SCIENCES INC Jun 23, 2026 reported Aug 12, 2026 President Donald J. Trump Periodic Transaction Report 08.12.26 $1,001 – $15,000
  4. Purchase: GILEAD SCIENCES INC Jun 15, 2026 reported Aug 12, 2026 President Donald J. Trump Periodic Transaction Report 08.12.26 $1,001 – $15,000
  5. Sale: GILEAD SCIENCES INC Jun 12, 2026 reported Aug 12, 2026 President Donald J. Trump Periodic Transaction Report 08.12.26 $1,001 – $15,000
  6. Sale: GILEAD SCIENCES INC May 18, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (2) $1,001 – $15,000
  7. Purchase: GILEAD SCIENCES INC May 15, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (2) $15,001 – $50,000
  8. Purchase: GILEAD SCIENCES INC Apr 27, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (1) $15,001 – $50,000
  9. Sale: GILEAD SCIENCES INC Apr 27, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (1) $15,001 – $50,000
  10. Purchase: GILEAD SCIENCES INC Apr 17, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (1) $1,001 – $15,000

Showing the latest 10 of 13.

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Oct 29, 2026
  2. Results of operations and financial condition filing Aug 4, 2026

Lobbying · Senate LDA reports

Lobbying filed

40 quarterly lobbying reports for 2026 naming Gilead Sciences, Inc. as the client: 4 filed by the company itself, 36 by outside firms it hired. Each line is one report as filed; an amended report is a line of its own. An outside firm states what the company paid it; the company's own report states its whole lobbying spend, which can include those fees, so the lines are not added up. Reports are collected in batches and a quarter can be missing here; the full record is at lda.gov.

  1. The company itself Q3 2026 filing $6.6M
  2. The company itself Q3 2026 filing $2.3M
  3. MILLER STRATEGIES, LLC Q3 2026 filing $150K
  4. THE DUBERSTEIN GROUP INC. Q3 2026 filing $90K
  5. FORBES-TATE Q3 2026 filing $80K
  6. TARPLIN, DOWNS & YOUNG, LLC Q3 2026 filing $80K
  7. FARRAGUT PARTNERS LLP Q3 2026 filing $80K
  8. TODD STRATEGY GROUP Q3 2026 filing $80K
  9. JEFFREY J. KIMBELL & ASSOCIATES, INC. Q3 2026 filing $75K
  10. CAPITOL TAX PARTNERS, LLP Q3 2026 filing $60K
  11. THE MCMANUS GROUP Q3 2026 filing $60K
  12. W STRATEGIES, LLC Q3 2026 filing $60K
  13. TIBER CREEK GROUP Q3 2026 filing $60K
  14. EMPIRE CONSULTING GROUP Q3 2026 filing $50K
  15. The company itself Q2 2026 filing $1.6M
  16. MILLER STRATEGIES, LLC Q2 2026 filing $150K
  17. FORBES-TATE Q2 2026 filing $90K
  18. THE DUBERSTEIN GROUP INC. Q2 2026 filing $90K
  19. TODD STRATEGY GROUP Q2 2026 filing $80K
  20. TARPLIN, DOWNS & YOUNG, LLC Q2 2026 filing $80K
  21. FARRAGUT PARTNERS LLP Q2 2026 filing $80K
  22. JEFFREY J. KIMBELL & ASSOCIATES, INC. Q2 2026 filing $75K
  23. CAPITOL TAX PARTNERS, LLP Q2 2026 filing $60K
  24. W STRATEGIES, LLC Q2 2026 filing $60K
  25. TIBER CREEK GROUP Q2 2026 filing $60K

Showing 25 of 40.

Sources: SEC EDGAR (Forms 4, 144 and 8-K), Senate LDA lobbying reports, OGE Form 278-T reports on whitehouse.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.